A transformational £1bn development aimed at revolutionising cancer research and treatment has taken a major step forward, as plans are officially submitted for a world-leading innovation centre in Sutton, south London.
Property investment firm Aviva Capital Partners and mixed-use developer Socius have submitted a comprehensive planning application to the London Borough of Sutton, seeking approval to significantly expand the existing London Cancer Hub. If approved, the development will turn a 12-acre site into a vibrant, collaborative ecosystem for cancer research, combining state-of-the-art laboratories, specialist facilities, and community-focused amenities.
Located adjacent to The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, the proposed development aims to create one of the most ambitious life sciences clusters in Europe, dedicated solely to oncology.
The design team, which includes renowned architect Gensler and global engineering consultancy Arup, has put forward plans for over one million square feet of advanced research and laboratory space. The aim is to bring together pharmaceutical giants, pioneering life sciences start-ups, academic researchers, and clinicians to accelerate breakthroughs in cancer prevention, diagnosis, and treatment.
The development isn’t just about buildings—it’s about building a community. At the heart of the proposal is a vision for an open, interconnected campus that fosters innovation through proximity and purpose-built collaboration spaces. From top-tier wet labs and GMP (Good Manufacturing Practice) facilities to flexible workspaces for smaller biotech firms, the site will cater to a wide range of scientific needs. Modern office spaces and shared amenities will help foster the exchange of ideas and create an inclusive environment that draws in talent from across the country—and beyond.
To support those working within the hub, the plans also include new lifestyle and community offerings. Around 220 affordable homes for key workers are proposed, alongside a selection of cafes and restaurants to create a lively campus feel. A crèche will provide vital support for working families, while a ‘Learning Lab’ with educational facilities aims to inspire local students and nurture the next generation of scientists, clinicians, and innovators.
The planning application is now in the hands of the London Borough of Sutton, with a decision expected in 2025. If approved, the development will mark a significant milestone not only for Sutton but for the UK’s wider ambition to become a global leader in life sciences and healthcare innovation.
Socius Managing Director Barry Jessup believes the London Cancer Hub represents a rare and powerful opportunity to reshape how cancer research is conducted. “There is a unique opportunity at the London Cancer Hub to deliver state-of-the-art lab and research facilities alongside two world-renowned institutions, The Institute of Cancer Research and The Royal Marsden, to supercharge investment into cancer research,” he said. “Our plans are not just about delivering new facilities to attract cutting-edge businesses; it is about reorienting the district so there is better connectivity between the buildings, more natural ‘collision points’ and places to meet to drive collaboration and innovation.”
The proposed layout of the campus places significant emphasis on the human experience—replacing isolated institutional buildings with a connected urban framework that encourages social interaction, knowledge sharing, and a sense of community. Outdoor spaces, pedestrian routes, and green infrastructure will all play a role in shaping the district into an accessible and attractive destination for workers, researchers, and visitors alike.
Councillor Barry Lewis, Leader of the London Borough of Sutton, hailed the submission as a major step towards fulfilling the borough’s strategic vision. “The London Cancer Hub will position Sutton as London’s global centre for oncology,” he stated. “Already recognised as a leading life science cluster in the capital, the site’s uniqueness lies in its current delivery of world-class cancer research, discoveries, and treatment all within a single location.”
He continued: “The life science sector and associated development will be pivotal to the future growth of the capital over the coming years, as recognised by the Mayor of London’s growth plan that names the London Cancer Hub as the key engine for this growth. The submission of this planning application marks a significant step forward in this exciting development for Sutton and the capital.”
The London Cancer Hub already enjoys a reputation for excellence, with The Royal Marsden and The Institute of Cancer Research frequently cited among the world’s leading institutions in oncology. This new development aims to build on that legacy by creating the infrastructure and environment needed to attract global investment, cutting-edge start-ups, and top-tier scientific talent.
With the NHS under increasing pressure and the global demand for advanced cancer treatment and research growing rapidly, this expansion could not come at a more critical time. It signals a bold, proactive step by both public and private sectors to ensure the UK remains at the forefront of medical innovation—while also delivering real economic benefits through job creation, regeneration, and global competitiveness.
The £1bn Sutton development stands to become not only a beacon of hope for those affected by cancer but also a vital driver of future economic growth. If approved, it will be a powerful demonstration of how long-term vision, cross-sector collaboration, and investment in science and health can reshape cities and save lives.
Building, Design & Construction Magazine | The Choice of Industry Professionals
